Chimera Investment Corp. Investing Cash Flow increased by 205.5% to $355.73M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 302.9%, from -$175.33M to $355.73M. Over 2 years (FY 2021 to FY 2025), Investing Cash Flow shows a downward trend with a -18.0% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $851.75M | $174.91M | $707.40M | -$187.35M | $356.58M | $486.30M | -$82.01M | -$110.89M | $367.87M | $376.79M | $248.34M | -$646.22M | $689.65M | -$175.33M | -$1.20B | $0.00 | -$337.04M | $355.73M |
| QoQ Change | — | -79.5% | +304.4% | -126.5% | +290.3% | +36.4% | -116.9% | -35.2% | +431.7% | +2.4% | -34.1% | -360.2% | +206.7% | -125.4% | -586.1% | +100.0% | — | +205.5% |
| YoY Change | — | — | — | — | -58.1% | +178.0% | +56.2% | -131.1% | -24.4% | — | +402.8% | -275.7% | +83.0% | -170.6% | — | +100.0% | -148.9% | +302.9% |